a new oral bisphosphonate for osteoporosis called Boniva (ibandronate)
December 2004
In 2005 you'll see a new oral bisphosphonate for osteoporosis called Boniva (ibandronate).
It'll be the first one approved for dosing once a MONTH.
Bisphosphonates are good candidates for intermittent dosing. They can remain active in the bone for several weeks or longer.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote